Controle da hipercolesterolemia e doenças coronarianas. Estado atual
Vila, José Henrique Andrade; Waitzberg, Dan L; Borges, Viviane Chaer.
An. paul. med. cir
; 120(3): 75-7, jul.-set. 1993. tab
Artigo Português | LILACS | ID: lil-128111
Documentos relacionados
The North Karelia Project (1972-1997) and the Origins of the Community Approach to Cardiovascular Disease Prevention.
[Cardiovascular prevention - 2016].
Attribution of risk for coronary heart disease in a vulnerable immigrant population: a survey study.
Cholesterol education program in the United States.
[Population surveillance and its importance in the study of the effectiveness of primary and secondary prevention of ischemic heart disease among the population].
Cholesterol Evaluation in Young Adults: Absence of Clinical Trial Evidence Is Not a Reason to Delay Screening.
[Cholesterol screening within the scope of preventive strategies].
[Cholesterol reducing food certainly is useful].
Challenges in coronary heart disease prevention - experiences from a long-term follow-up study in Norway.
The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice.